Journal List > J Korean Ophthalmol Soc > v.55(4) > 1009948

Cho, Kim, Han, Chung, and Park: Clinical Manifestations of Ocular Syphilis Combined with Neurosyphilis

Abstract

Purpose

To report the manifestation of ocular syphilis combined with neurosyphilis in patients who present with uveitis clinically and are diagnosed initially by an ophthalmologist.

Methods

This study is a retrospective, clinical investigation of seven male patients with ocular syphilis from a single tertiary center between 2009 and 2012.

Results

The average age of the patients at onset was 44.4 years (range, 33-71 years). Posterior segment involvement was found in all patients. Two patients had papillitis. In serologic testing, all patients had positive responses to Venereal Disease Research Laboratory (VDRL), fluorescent treponemal antibody-absorption test (FTA-ABS) and Treponema pallidum hemag-glutination (TPHA). In fluorescein angiography (FAG), retinal vascular and disc leakage was the most common finding. Cerebrospinal fluid (CSF) analysis was performed for six patients and demonstrated positive CSF FTA-ABS and CSF TPHA tests in all patients. CSF VDRL was reactive in 2 patients (33.3%).

Conclusions

All patients with ocular syphilis were diagnosed with neurosyphilis based on the analysis of CSF with FTA-ABS and TPHA. Ophthalmologists play an important role in the early diagnosis and treatment of syphilis.

References

1. Herida M, Michel A, Goulet V, et al. Epidemiology of sexually transmitted infections in France. Med Mal Infect. 2005; 35:281–9.
2. Parc CE, Chahed S, Patel SV, Salmon-Ceron D. Manifestations and treatment of ocular syphilis during an epidemic in France. Sex Transm Dis. 2007; 34:553–6.
crossref
3. Doris JP, Saha K, Jones NP, Sukthankar A. Ocular syphilis: the new epidemic. Eye (Lond). 2006; 20:703–5.
crossref
4. Aldave AJ, King JA, Cunningham ET Jr. Ocular syphilis. Curr Opin Ophthalmol. 2001; 12:433–41.
crossref
5. Brown DL, Frank JE. Diagnosis and management of syphilis. Am Fam Physician. 2003; 68:283–90.
6. Chao JR, Khurana RN, Fawzi AA, et al. Syphilis: reemergence of an old adversary. Ophthalmology. 2006; 113:2074–9.
crossref
7. Piñón-Mosquera R, Jiménez-Benito J, Olea-Cascón J. Syphilitic bilateral panuveitis: a case report. Arch Soc Esp Oftalmol. 2009; 84:101–4.
8. Anshu A, Cheng CL, Chee SP. Syphilitic uveitis: an Asian perspective. Br J Ophthalmol. 2008; 92:594–7.
crossref
9. Pan SW, Yusof NS, Hitam HW, et al. Syphilitic uveitis: report of 3 cases. Int J Ophthalmol. 2010; 3:361–4.
10. Kim HB, Kwon OW, Chun GH. Bilateral tonic pupil in syphilis. J Korean Ophthalmol Soc. 1983; 24:877–81.
11. Lee YH, Nam K, Kim JY. Cilioretinal artery occlusion as the first clinical manifestation of ocular syphilis. J Korean Ophthalmol Soc. 2011; 52:1254–8.
crossref
12. Barile GR, Flynn TE. Syphilis exposure in patients with uveitis. Ophthalmology. 1997; 104:1605–9.
crossref
13. Amaratunge BC, Camuglia JE, Hall AJ. Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin Experiment Ophthalmol. 2010; 38:68–74.
crossref
14. Browning DJ. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology. 2000; 107:2015–23.
crossref
15. Yang P, Zhang N, Li F, et al. Ocular manifestations of syphilitic uveitis in Chinese patients. Retina. 2013; 32:1906–14.
crossref
16. Centers for Disease Control. 1989 Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep. 1989; 38:1–43.
17. Tran TH, Cassoux N, Bodaghi B, et al. Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefes Arch Clin Exp Ophthalmol. 2005; 243:863–9.
crossref
18. Fonollosa A, Giralt J, Pelegrıin L, et al. Ocular syphilis-back again: understanding recent increases in the incidence of ocular syphilitic disease. Ocul Immunol Inflamm. 2009; 17:207–12.
crossref
19. Li SY, Birnbaum AD, Tessler HH, Goldstein DA. Posterior syphilitic uveitis: clinical characteristics, co-infection with HIV, response to treatment. Jpn J Ophthalmol. 2011; 55:486–94.
crossref
20. Marra CM, Critchlow CW, Hook EW 3rd, et al. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol. 1995; 52:68–72.
crossref

Figure 1.
Photographs of Patient 2. (A) A right eye fundus photograph, at the first visit, shows normal retinal appearance. (B) A left eye fundus photograph, at the fist visit, shows subfoveal exudation and macular edema. (C) A right eye fluorescein angiograph at the mid-phase shows peirvascular and multiple RPE leakage at the super-otemporal quaderant. (D) A left eye fluorescein angiograph at the mid-phase shows macular pooling of dye and peripheral PRE active leakage. (E) A right eye fundus photograph, at the last visit, shows normal retinal appearance. (F) A left eye fundus photograph, at the last visit, shows subfoveal exudation and macular edema resolved.
jkos-55-602f1.tif
Table 1.
Demographics, clinical findings of ocular syphilis
Patient Age/ Sex Presenting VA (OD; OS) Anterior segment Posterior segment FAG Response (as of last follow-up) Follow-up (from start of Tx) Final VA (OD; OS)
1 40/M 10/20020/20 Iridocyclitis, KP, OD Vitreous opacity, snow ball, salt pepper like OD) Diffuse leakage, Disc leakage (optic neuritis), Diffuse retinal Degeneration 3 years 20/2020/20
      app., Hyperemic disc, OD late phase macular diffuse edema      
2 42/M 20/32 Clear, OU Vitreous opacity, ME, OD) Multifocal leaking in Resolution 1 year 20/20
  20/200   OS: Subfoveal exudation, exudative elevation, OS RPE, macular edema, disc leakage OS) Macular pooling of dye, peripheral PRE active leakage vitreous opacity, Decreased macular exudation, OS   20/20
3 71/M 20/10020/20 Clear, OU ERM, OD; PED, OS: RPE degeneration, OU OU) window defect OD) Epiretinal membrane, vascular leakage ERM, OD: PED, OS 1 year 20/4020/20
4 40/M 20/40 Clear, OU Temporal branch OD) vascular leakage Temporal branch 9 months 20/32
  20/50   perivascular sheathing, venous bleeding, retinal Hx., RPE degeneration, snow ball, OU : Peripheral vascular OS) vascular leakage, branch vein occlusion perivascular sheathing, retinal hemorrhage, OS   20/32
      occlusion (retinal vasculitis), OD        
5 33/M 20/12520/20 Clear, OU Disc swelling, disc hyperemia marginal blurring, OU; OU) disc leakage, venous tortuosity, OD) vascular leakage Disc swelling, disc hyperemia marginal blurring, 1 year 20/4020/20
      exudation macular, vasculitis, OS (Post optic neuritis steroid Medication state, OS) OS) vascular leakage, macular edema OD    
6 36/M 20/20020/20 Clear, OU Vitritis, vasculitis, macular hypopigmentation, OD OD) vascular leakage, disc leakage Resolution vitritis and vasculitis, OD 4 months 20/3220/20
7 49/M 20/20020/40 Clear, OU RPE degeneration, macular degeneration, OD OD) vascular leakage OS) vascular leakage, disc leakage Remain 4 months 20/3220/20

FAG = fluorescein angiography; Tx = treatment; KP = keratic precipitate; ERM = epiretinal membrane; PED = pigment epithelium detachment; RPE = retinal pigment epithelium.

Table 2.
Cerebrospinal fluid (CSF) findings
Patients Age/Sex WBC count (0-5 cells/mm3) Glucose (>50 mg/dL) Protein (20-40 mg/dL) CSF
FTA-ABS TPHA VDRL
1 40/M 32 61 46 Reactive Reactive Reactive
2 42/M 7 88 39 Reactive Reactive Non-Reactive
3 71/M UC UC UC UC UC UC
4 40/M 23 55 32 Reactive Reactive Non-Reactive
5 33/M 7 57 39 Reactive Reactive Non-Reactive
6 36/M 7 62 53 Reactive Reactive Non-Reactive
7 49/M 4 127 81 Reactive Reactive Reactive

WBC = white blood cell; FTA-ABS = fluorescent treponemal antibody absorption test; TPHA = treponema pallidum hem-agglutination test; VDRL = venereal disease research laboratory test; UC = unchecked.

TOOLS
Similar articles